Using our knowledge of the shared clinical, pathological, and genetic features characterizing ALS and FTD, a systems‐level proteomic analysis of both sporadic and genetic (C9orf72) cases comprising the ALS‐FTD spectrum was conducted to determine common and distinct pathways that contribute to the onset and development of dementia. This evidence concerns the gene C9orf72 and frontotemporal dementia.